Publication | Closed Access

An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates

Fda Oncology AnalysisDrug TargetingOncologyPolymer-drug ConjugateMedicinePbd-containing Antibody-drug ConjugatesPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyCancer Research